Biotech Firm Claims Some Credit for Groundbreaking Virus Research

Start

Radical Numerics turned heads with its announcement about a novel treatment. Now a former partner, Tabula Bioscience, says it performed much of the research.

Previous Story

Microsoft’s Buyout Offer Sets Its Workforce on Edge